WWP1 targets HER4 CYT1 for ubiquitination and degradation, thereby preventing HER4 signaling and breast tumorigenesis [108], which could have implications for developing therapies aimed at modulating HER4 signaling in breast cancer. This evidence concerns the gene WWP1 and breast carcinoma.